UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 196

Sortiert nach

Opioid Monitoring in Clinical Settings: Strategies and Implications of Tailored Approaches for Therapy

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5925

2024

Volltextzugriff (PDF)

Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10754

2023

Volltextzugriff (PDF)

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study

Scientific reports, 2022-06, Vol.12 (1), p.10126-10126, Article 10126

2022

Volltextzugriff (PDF)

Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences

Acta pharmaceutica (Zagreb, Croatia), 2023-06, Vol.73 (2), p.227-241

2023

Volltextzugriff (PDF)

Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients

Basic & clinical pharmacology & toxicology, 2019-04, Vol.124 (4), p.439-448

2019

Volltextzugriff (PDF)

Epigenetic and sex differences in opioid use disorder in chronic pain: A real‐world study linked with OPRM1 DNA methylation

Addiction biology, 2024-07, Vol.29 (7), p.e13422-n/a

2024

Volltextzugriff (PDF)

Sleep problems in adults with autism spectrum disorder and intellectual disability

Autism research, 2019-01, Vol.12 (1), p.66-79

2019

Volltextzugriff (PDF)

Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study

Pharmaceuticals (Basel, Switzerland), 2023-10, Vol.16 (10), p.1496

2023

Volltextzugriff (PDF)

OPRM1 Gene Interaction with Sleep in Chronic Pain Patients Treated with Opioids

Pain physician, 2019-01, Vol.22 (1), p.97-107

2019

Volltextzugriff (PDF)

Gender based differences, pharmacogenetics and adverse events in chronic pain management

The pharmacogenomics journal, 2020-04, Vol.20 (2), p.320-328

2020

Volltextzugriff (PDF)

Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study

Acta Pharmaceutica, 2022-12, Vol.72 (4), p.529-545

2022

Volltextzugriff (PDF)

Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study

International journal of impotence research, 2021-04, Vol.33 (3), p.339-347

2021

Volltextzugriff (PDF)

CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis

Pharmaceuticals (Basel, Switzerland), 2023-07, Vol.16 (7), p.954

2023

Volltextzugriff (PDF)

The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability

Autism research, 2022-01, Vol.15 (1), p.192-202

2022

Volltextzugriff (PDF)

OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients

Annals of the New York Academy of Sciences, 2018-08, Vol.1425 (1), p.82-93

2018

Volltextzugriff (PDF)

Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability

Journal of psychopharmacology (Oxford), 2019-11, Vol.33 (11), p.1395-1406

2019

Volltextzugriff (PDF)

Health benefits of an adverse events reporting system for chronic pain patients using long‐term opioids

Acta anaesthesiologica Scandinavica, 2019-02, Vol.63 (2), p.248-258

2019

Volltextzugriff (PDF)

Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects

Clinical drug investigation, 2020-07, Vol.40 (7), p.617-628

2020

Volltextzugriff (PDF)

Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients

Frontiers in cardiovascular medicine, 2024-03, Vol.11, p.1301925-1301925

2024

Volltextzugriff (PDF)

Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain

Journal of clinical medicine, 2023-05, Vol.12 (10), p.3449

2023

Volltextzugriff (PDF)

Use of analgesics in professional soccer players: A systematic review

Apunts sports medicine, 2023-07, Vol.58 (219), p.100415, Article 100415

2023

Volltextzugriff (PDF)

Impact of Hydrothermal Processing Conditions on High Aspect Ratio Titanate Nanostructures

Chemistry of materials, 2006-12, Vol.18 (25), p.6059-6068

2006

Volltextzugriff (PDF)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study

Biomedicines, 2022-10, Vol.10 (10), p.2468

2022

Volltextzugriff (PDF)

Association of cannabinoid receptor genes (CNR1 and CNR2) polymorphisms and panic disorder

Anxiety, stress, and coping, 2020-05, Vol.33 (3), p.256-265

2020

Volltextzugriff (PDF)

Pharmacogenetic use in clinical practice: treatment of pain

Medicina clinica, 2013-12, Vol.141 (11), p.501

Peiró Peiró, Ana M

2013

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Opioid Monitoring in Clinical Settings: Strategies and Implications of Tailored Approaches for Therapy

Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study

Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences

Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients

Epigenetic and sex differences in opioid use disorder in chronic pain: A real‐world study linked with OPRM1 DNA methylation

Sleep problems in adults with autism spectrum disorder and intellectual disability

Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study

OPRM1 Gene Interaction with Sleep in Chronic Pain Patients Treated with Opioids

Gender based differences, pharmacogenetics and adverse events in chronic pain management

Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study

Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study

CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis

The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability

OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients

Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability

Health benefits of an adverse events reporting system for chronic pain patients using long‐term opioids

Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects

Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients

Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain

Use of analgesics in professional soccer players: A systematic review

Impact of Hydrothermal Processing Conditions on High Aspect Ratio Titanate Nanostructures

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study

Association of cannabinoid receptor genes (CNR1 and CNR2) polymorphisms and panic disorder

Pharmacogenetic use in clinical practice: treatment of pain

Suchergebnisse filtern